• Transfer to maximise synergies and sharpen focus on growth
    Ben Cliff CEO Concept Life Sciences

Company News

Transfer to maximise synergies and sharpen focus on growth

Oct 31 2023

Concept Life Sciences, a leading drug discovery, development and manufacturing organisation, has carved out its Bradford analytical chemistry business to Cormica, a specialist in testing services for medical device and pharmaceutical manufacturers.

As both companies are part of the healthcare portfolio of private equity house, Limerston Capital LLP, the seamlessly executed agreement includes the transfer of all employees to Cormica who will remain located at the Bradford office with business contining as normal.

Having recently undergone a significant brand exercise, the new identity and name aligns with Cormica’s strategy for expansion in the UK, US and European markets through acquisition and organic growth.

The divestment of the Bradford business also allows Concept Life Sciences to sharpen its focus on its core service offerings, spanning from drug discovery to early-stage development pathways. Established in 2017 through the acquisition of various enterprises, the company, acquired by Limerston Capital earlier this year, is renowned for its expertise in the pharmaceutical, biotech and agrochemical sectors.

Mark Hammond, CEO of Cormica, said: “Cormica has an ambitious growth strategy, trained on full service regulated testing across, physical, chemical and microbiology. We know the Bradford business and its team well and the opportunity to strengthen our expertise in analytical chemistry will significantly strengthen our market position and provide an enhanced service to our customers."

“The deal made sense on a variety of levels, and, thanks to our existing relationship, was relatively simple to facilitate. We are now looking forward to integrating the team into Cormica and to identifying the immediate opportunities this will bring.”

Ben Cliff, CEO of Concept Life Sciences, added: “It has been a busy year for the business, and we have had the much-needed chance to review our operations and our longer-term strategy which will help us to realise the company’s full potential.

“Bradford has been an important part of our story so far; however its offerings align much more closely with Cormica which has a shared customer base and audiences. This deal will allow us to concentrate on our core service lines, working with our highly skilled team to drive our work in key markets.”

More information online


Digital Edition

ILM 49.5 July

July 2024

Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...

View all digital editions


ADLM 2024

Jul 28 2024 San Diego, CA USA

InaLab 2024

Jul 30 2024 Jakarta, Indonesia


Jul 31 2024 Chengdu, China

ACS National Meeting - Fall 2024

Aug 18 2024 Denver, CO, USA


Aug 25 2024 Copenhagen, Denmark

View all events